Letters to the Editor
Consider Gout in Patients with Risk Factors, Regardless of Age
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2008 Jul 15;78(2):176.
Original Article: Gout: An Update
Issue Date: September 15, 2007
Available at: http://www.aafp.org/afp/20070915/801.html
to the editor: Thank you for the informative overview of gout provided in the article by Dr. Eggebeen. I am particularly pleased that he emphasized the importance of initiating non-pharmacologic treatment of hyperuricemia to reduce the frequency of recurrence and chronic sequelae.
Physicians should also have a high clinical suspicion in young adult men whose lifestyle involves the consumption of red meat, seafood, alcohol, and exercises that may trigger the onset of gout. Although epidemiologic studies continue to support a higher prevalence of gout in older men, with peak incidence in the fifth decade (51 to 59 years),1 it is important to remember that prevalence is dependent on the incidence and duration of the disease. Also, serum urate levels change dramatically in males from mean childhood values to adult levels during puberty.1 Although the disease has a low prevalence in young adults, those with a genetic predisposition and lifestyle risk factors may experience their first episode of gout in their early 20s.
The perception that acute gout is a disease that only affects older men may lead to a delay in the identification of new cases in young men. This may delay the start of treatment beyond the first 36 hours of the attack when treatment with colchicine and nonsteroidal anti-inflammatory drugs are most effective in reducing the duration of symptoms.
Author disclosure: Nothing to disclose.
The opinions and assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the U.S. Air Force or U.S. Army Medical Departments, or the U.S. Air Force or U.S. Army Services at large.
1. Terkeltaub RA. Gout: epidemiology, pathology, and pathogenesis. In: Klippel JH, Weyand CM, Wortmann R. Primer on the Rheumatic Diseases. 11th ed. Atlanta, Ga.: Arthritis Foundation; 1997:230–234.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2008 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions